+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia



Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia



Neurobiology of Disease 87: 69-79



Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons. The gold standard therapy relies on dopamine (DA) replacement by the administration of levodopa (l-DOPA). However, with time l-DOPA treatment induces severe motor side effects characterized by abnormal and involuntary movements, or dyskinesia. Although earlier studies point to a role of striatal cholinergic interneurons, also known as striatal tonically active neurons (TANs), in l-DOPA-induced dyskinesia (LID), the underlying mechanisms remain to be fully characterized. Here, we find that DA depletion is accompanied by increased expression of choline acetyltransferase (ChAT), the vesicular acetylcholine transporter (VAChT) as well as the atypical vesicular glutamate transporter type 3 (VGLUT3). TANs number and soma size are not changed. In dyskinetic mice, the VAChT levels remain high whereas the expression of VGLUT3 decreases. LID is attenuated in VGLUT3-deficient mice but not in mice bearing selective inactivation of VAChT in TANs. Finally, the absence of VGLUT3 is accompanied by a reduction of l-DOPA-induced phosphorylation of ERK1/2, ribosomal subunit (rpS6) and GluA1. Our results reveal that VGLUT3 plays an important role in the development of LID and should be considered as a potential and promising therapeutic target for prevention of LID.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791245

Download citation: RISBibTeXText

PMID: 26711621

DOI: 10.1016/j.nbd.2015.12.010


Related references

Axonal Segregation and Role of the Vesicular Glutamate Transporter VGLUT3 in Serotonin Neurons. Frontiers in Neuroanatomy 10: 39, 2016

Role of the vesicular transporter VGLUT3 in retrograde release of glutamate by cerebellar Purkinje cells. Journal of Neurophysiology 105(3): 1023-1032, 2011

Locally collateralizing glutamate neurons in the dorsal raphe nucleus responsive to substance P contain vesicular glutamate transporter 3 (VGLUT3). Journal of Chemical Neuroanatomy 38(4): 273-281, 2010

Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience 123(4): 983-1002, 2004

Coincidence of neurokinin 1 receptor with the vesicular glutamate transporter 3 (VGLUT3) in the rat forebrain. Neuroscience Letters 464(3): 188-192, 2009

Comparison of the ontogeny of the vesicular glutamate transporter 3 (VGLUT3) with VGLUT1 and VGLUT2 in the rat retina. Brain Research 1215: 20-29, 2008

The vesicular glutamate transporter VGLUT3 contributes to protection against neonatal hypoxic stress. Journal of Physiology 590(20): 5183-5198, 2013

Nonserotonergic projection neurons in the midbrain raphe nuclei contain the vesicular glutamate transporter VGLUT3. Synapse 63(1): 31-41, 2008

VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. Journal of Neuroscience 30(6): 2198-2210, 2010

Vesicular glutamate transporter 3 (VGLUT3) identifies spatially segregated excitatory terminals in the rat substantia nigra. European Journal of Neuroscience 23(4): 1063-1070, 2006

Evidence for a third vesicular glutamate transporter isoform vglut3 cloning,functional characterization and distribution in mouse brain. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 343 1, 2002

GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat. European Journal of Neuroscience 19(3): 552-569, 2004

Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. American Journal of Human Genetics 83(2): 278-292, 2008

The expression of vesicular glutamate transporter 3 and vesicular monoamine transporter 2 induced by brain-derived neurotrophic factor in dorsal root ganglion neurons in vitro. Brain Research Bulletin 100: 93-106, 2014

Changes in vesicular glutamate transporter 2, vesicular GABA transporter and vesicular acetylcholine transporter labeling of sacrocaudal motoneurons in the spastic rat. Experimental Neurology 197(2): 407-419, 2005